K-RasG12D–induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to γ-secretase inhibitors
Open Access
- 15 October 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 112 (8) , 3373-3382
- https://doi.org/10.1182/blood-2008-03-147587
Abstract
To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we made use of a conditional K-RasG12D murine knockinKeywords
This publication has 57 references indexed in Scilit:
- FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitorsThe Journal of Experimental Medicine, 2007
- The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemiaThe Journal of Experimental Medicine, 2007
- Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemiaBlood, 2007
- Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathwaysBlood, 2007
- A Microenvironment-Induced Myeloproliferative Syndrome Caused by Retinoic Acid Receptor γ DeficiencyCell, 2007
- Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow MicroenvironmentCell, 2007
- Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivoBlood, 2006
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991